Site icon pharmaceutical daily

Worldwide Over the Counter Drugs Industry to 2025 – Competitive Analysis and the Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Over the Counter Drugs Market (2020-2025) by Mode of Intake, Product, End-user Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The global over the counter drugs market is estimated to be $361 billion in 2020 and is expected to reach $539 billion by 2025, growing at a CAGR of 8.35%.

Increasing awareness regarding the personalized medicine for treating minor ailments and introduction of treatment protocols by healthcare payers and also rapidly increasing chronic diseases are some of the major driving factors making remarkable new drug development and impact positively the expansion of the over the counter (OTC) drugs market. In fact, the proper drug for the proper patient at the proper time is the mantra of personalized medicine.

Companies Mentioned

Recent Developments

1. In July 2020, Stada AG, a Germany-based pharmaceutical company, announced about acquisition of 15 of deep-rooted OTC brands from GlaxoSmithKline in Europe. The acquisition will strengthen the company’s portfolio and presence in the consumer health business.

2. In January 2018, Nuvo Pharmaceuticals, Inc. acquired ex-U.S. product and existing royalty streams for ‘Resultz’, an OTC treatment for head lice from Piedmont Pharmaceuticals LLC.

3. Takeda Pharmaceuticals in March 2016, started overseas sales of OTC brand – Alinamin in Vietnam, India, Hong-Kong, and China.

Why buy this report?

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Overview

4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Improvement in lifestyle and age related diseases

4.2.1.2 The rise in self-directed consumer

4.2.1.3 Growing awareness regarding general health concerns and advancements in healthcare industry

4.2.2 Restraints

4.2.2.1 Stringent regulatory policies by governing bodies

4.2.2.2 Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs

4.2.3 Opportunities

4.2.3.1 Increasing R&D expenditure and funding from the public & private sector

4.2.4 Challenges

4.2.4.1 Firms are seeking portfolio expansion strategies to cater to the growing demand for over-the-counter drugs.

4.3 Trends

5 Market Analysis

5.1 Porter’s Five Forces Analysis

5.2 Impact of COVID-19

5.3 Ansoff Matrix Analysis

6 Global Over the Counter Drugs Market, By Mode of Intake

6.1 Introduction

6.2 Topical

6.3 Oral

6.4 Parenteral

7 Global Over the Counter Drugs Market, By Product

7.1 Analgesics

7.2 Weight Loss/Dietary Products

7.3 Gastrointestinal Products

7.4 Cold, Cough and Flu Products

7.5 Mineral and Vitamin Supplements

7.6 Skin Products

7.7 Ophthalmic Products

7.8 Sleeping Aids

7.9 Dermatology Products

8 Global Over the Counter Drugs Market, By End User

8.1 Introduction

8.2 Retail Pharmacies

8.3 Online Pharmacies

8.4 Hospital Pharmacies

9 Global Over the Counter Drugs Market, By Geography

9.1 Introduction

9.2 North America

9.3 South America

9.4 Europe

9.5 Asia-Pacific

9.6 Rest of the World

10 Competitive Landscape

10.1 Competitive Quadrant

10.2 Market Share Analysis

10.3 Competitive Scenario

10.3.1 Mergers & Acquisitions

10.3.2 Agreement, Collaborations, & Partnerships

10.3.3 New Product Launches & Enhancements

10.3.4 Investments & Funding

11 Company Profiles

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/mvg1cx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version